Confusion, anger arises over NACI’s mixed message on ‘favorite’ COVID-19 vaccine


The National Advisory Committee on Immunization is coming under fire after Canadians have been receiving weeks to take the first vaccine against COVID-19 that they are offering.

NACI said on Monday that Pfizer-BioNotech and Modern Vaccines are “favorites” and that Canadians risk waiting for one of them before deciding to take one or more of the other two immediate jabs approved for use in Canada Should be raised.

Johnson & Johnson and AstraZeneca vaccines have been linked to a new and extremely rare blood-clotting syndrome.

Read more:

NACI recommends Johnson & Johnson Kovid-19 shot for those 30 and older, mRNA said

Because of this, the vice chairman of the committee, Drs. Shelley Deeks said that a person working from home in a province where there is not much disease wants to wait for a shot of Pfizer or modern vaccines.

Story continues under advertisement

But she said it would be a very different risk-benefit analysis for someone working in a manufacturing plant without personal protective equipment in the province where COVID-19 is spreading like wildfire.

NACI’s advice appears to contradict Health Canada’s long-standing recommendation that the best vaccine is available first.

Some doctors took to social media to reject NACI’s latest advice, warning that the committee was causing confusion and increasing vaccine hesitation.

Emergency Physician Dr. Brian Goldman said on Twitter, “It hurts me to say this but it’s time to take the NACI recommendations with a grain of salt.”

“For the betterment of your health, don’t get it wrong when it comes to #covidvaccines. Take the first item you give.”

Those who became innocent with AstraZeneca also took to social media to express anger that they were hoodwinked into getting a second-rate vaccine, while others questioned whether they should cancel the first plan for that vaccine Or refusal to take a second dose.


Click to play video: 'Quebec woman dies of blood clot after receiving AstraZeneca vaccine'



Quebec woman’s blood clot dies after receiving the AstraZeneca vaccine


Quebec woman’s blood clot dies after receiving the AstraZeneca vaccine

One Twitter user noted on the acidity that NACI’s advice “boils down to people who are at risk, they should compromise for the most high-risk vaccine because they are the most at risk.”

Story continues under advertisement

NACI chair, Drs. Carolyn Quach-Thanh only made matters worse when she tried to explain the committee’s advice during an interview on CTV’s Power and Politics on Monday.

“If for example my sister got the AstraZeneca vaccine and when I found out that it could be stopped, died of a thrombosis and she is not in a high-risk area, I’m not sure I could live with it. ,” He said.

The risk of a new blood-clotting syndrome known as vaccine-induced thrombotic thrombocytopenia, or VITT, is estimated to be anywhere from one case per 100,000 doses to one given in 250,000. But the syndrome is so new, there is still little information about what the real risk is, why it is occurring and who is most likely to develop clots.

In Canada, seven cases have been reported of all people receiving the AstraZeneca vaccine. Some 1.7 million doses were given by 24 April.

As of April 23, out of more than eight million doses of the J&J vaccine administered in the United States, 17 cases of VITT were confirmed.

Read more:

Why All COVID-19 Vaccine Side Effects Matter, Not Only Serious

Health Canada has approved the J&J for use in Canada, but none of the Canadians have received it because the first batch given last week is still under investigation, security at the US facility involved in its production and After a quality control violation was reported.

Story continues under advertisement

NACI states that people in the provinces and territories may want to prioritize J & J, the only single-shot vaccine ever approved in Canada, for people who have difficulty scheduling a second dose. It recommends that Jammu and Kashmir, like AstraZeneca, be given only to people over 30 years of age.

Conservative MP Michelle Rempel Garner has raised confusion over the NACI’s latest advice in the House of Commons on Monday.

“It’s very different from what we’re hearing.” Does Health Canada recommend taking or waiting for the first vaccine for an mRNA (Pfizer or Modern) vaccine? ” He asked.

Health Minister Patty Hajdu replied that Health Canada is responsible for approving vaccines for use while NACI gives the best advice to advise them. He advised Canadians to ask their health care provider which vaccine is right.


Click to play video: 'NACI recommends AstraZeneca COVID-19 vaccine for Canadian 30+'



NACI recommends AstraZeneca COVID-19 vaccine for Canadian 30+


NACI recommends AstraZeneca COVID-19 vaccine for Canadian 30+ – April 23, 2021

AstraZeneca and J&J are both viral-vector vaccines, a technique that takes a common cold virus, manipulates it so that it doesn’t make anyone sick, and then engages the spike proteins of the SARS-CoV-2 virus Which causes COVID – 19. The vaccine helps the body mount an immune response that will recognize and fight an actual SARS-CoV-2 virus if it ever comes into contact with one.

Story continues under advertisement

Pfizer and Moderna use the mRNA technique, attaching the spike protein to a molecule that sends a message to the body to perform certain functions. In this case the message is to mount an immune response to the SARS-CoV-2 virus.

In Canada so far, 12.8 million people have received at least one dose of a vaccine. About two-thirds of them received Pfizer, one-fifth received Modern and the rest AstraZeneca.

View link »


© 2021 Canadian Press

.

Latest articles

Related articles